The catch, however, is that the product will be sold only in Israel, where pharmaceutical company Teva Pharm signed an agreement to market a medical marijuana inhaler previously used in a hospital, Reuters reported.
The company said this is the first time the medical marijuana industry has complied with pharmaceutical standards for inhaling the plant, which is the most efficient way to administer it.
Teva, which is the world’s largest generic drugmaker, will exclusively market and distribute the inhaler. It will be available for home use pending approval from Israel’s Ministry of Health. [Read more at TIME]
Good news for medical marijuana users: You may soon be able to buy a weed inhaler.